The Shifting Landscape of a Fentanyl Adulterant: Moving From Xylazine to Medetomidine
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
The Shifting Landscape of a Fentanyl Adulterant: Moving From Xylazine to Medetomidine
-
ナレーター：
-
著者：
In this episode, Dr. Jeanmarie Perrone sits down to discuss her new article The Shifting Landscape of a Fentanyl Adulterant: Moving From Xylazine to Medetomidine featured in the May/June issue of the Journal of Addiction Medicine.
Jeanmarie Perrone, MD is a Professor in the Department of Emergency Medicine, the Director of Addiction Toxicology, and the founding Director of the Penn Center for Addiction Medicine and Policy, all at the University of Pennsylvania. Dr. Perrone has led multiple initiatives through the emergency department for the initiation of treatment for substance use disorders. Dr. Perrone has been recognized with several awards for education and mentorship and is board certified in emergency medicine, medical toxicology and addiction medicine.
Article Link: The Shifting Landscape of a Fentanyl Adulterant: Moving From Xylazine to Medetomidine